Single-Blind, Randomized, Controlled Pilot Trial of a Cognitive-Behavioral Therapy Digital Therapeutic Delivered Online for Post-Traumatic Headaches in Adults With History of Concussive Traumatic Brain Injury
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Post-Traumatic Headache
- Sponsor
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- 6-Item Headache Impact Test™ (HIT-6™)
- Status
- Active, not recruiting
- Last Updated
- 7 months ago
Overview
Brief Summary
The AMMO digital therapeutic (DTx) study will provide an online based program for participants with migraines after head injury to follow for 12 weeks. This study aims to see if using cognitive behavioral therapy aimed at military service members in an online self administered platform is effective therapy in the relief of migraines compared. The study will use a single blind online comparative program to test the effect.
Detailed Description
The AMMO digital therapeutic (DTx) will be a novel intervention for PTH following concussive TBI, therefore this project is a pilot trial designed to test this new treatment. This pilot is a single-blind, randomized, controlled, interventional trial of current and former military personnel along with civilians with a history of concussive TBI and current PTH. The pilot trial will be conducted via online portal accessible by smartphone, tablet, or computer with remote interaction between participants and study staff. The pilot trial will include up to 100 participants randomized to either the active intervention or a comparison condition at a 1:1 ratio, and will provide preliminary data to determine the sample size of a future full clinical trial. Participants will complete a 12 week intervention period followed by a follow-up assessment 4 weeks after intervention is complete. Participants randomized to the comparison group will be provided access to the open label after end of 16 week follow-up. In addition, updates to the DTx to improve usability and acceptability will be made if necessary based on feedback from the pilot trial, then applied to the final DTx used in a future, larger, clinical trial.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Be aged ≥ 18 to ≤ 70 years
- •Have a history of concussive TBI ≥ 3 months prior to enrollment:
- •A concussive TBI is defined by having at least one of the following after a head trauma (ACRM, 1993) oAny period of loss of consciousness; oAny loss of memory for events immediately before or after the accident; oAny alteration in mental state at the time of the accident (e.g., feeling dazed, disoriented, or confused); and oFocal neurological deficit(s) that may or may not be transient oThe injury must not exceed any of the following (ACRM, 1993):
- •Loss of consciousness of approximately 30 minutes or less;
- •After 30 minutes an initial GCS score of 13-15; and
- •PTA not greater than 24 hours
- •Head trauma resulting in concussive TBI can be due to blast or non-blast mechanisms
- •Head trauma resulting in concussive TBI can have occurred any time in the participant's life: prior to military service, during deployment, in garrison, or after leaving military service
- •Have a history of chronic PTH defined as:
- •o Headache is reported to have developed (or worsened) after one of the following\*:
Exclusion Criteria
- •They experienced a moderate or severe TBI
- •Their secondary headache is better accounted for by the ICHD-3 diagnosis of 8.2 medication-overuse headache; must meet diagnostic criteria for at least 1 medication-overuse headache diagnosis (8.2.1-8.2.8)
- •They are currently engaged in psychotherapeutic treatment or have engaged in psychotherapeutic treatment within 8 weeks prior to trial enrollment (for more information regarding recent treatment in potential participants, see section '3.2 Study Procedures,' sub-section 'Baseline Evaluation')
- •They report change or discontinuation of headache prophylaxis in the past 4 weeks
- •They report active psychotic or bipolar symptoms
- •In the opinion of the investigator, they have other considerations that may adversely affect patient safety, participation, or scientific validity of the data being collected (including, but not limited to, active plan or intent for suicide, visual impairment, hand dysfunction or amputation, substantial cognitive impairment, life expectancy of less than 6 months)
Outcomes
Primary Outcomes
6-Item Headache Impact Test™ (HIT-6™)
Time Frame: 16 weeks
The HIT-6™ is a brief standardized headache screening tool and questionnaire, derived from the original 54-item Headache Impact Test. It has been found to have good psychometric properties in assessing headache impact among patients in clinical practice and research (Bjorner, Kosinski, \& Ware, 2003; Kosinski et al., 2003).
Secondary Outcomes
- Determine the appropriate sample size for a future full clinical trial based on preliminary estimates of effect size for outcome measures(12 weeks)
- Post Traumatic Stress Disorder Checklist (DSM-5)(16 weeks)
- Traumatic Brain Injury Quality of Life Scale (TBI-QOL)(16 weeks)
- Patient Health Questionnaire-9(16 weeks)
- Insomnia Severity Index (ISI)(16 weeks)
- User Version of the Mobile Application Rating Scale(12 weeks)
- Mobile Agnew Relationship Measure(12 weeks)
- User Program Feedback Questionnaire(12 weeks)